Breast Cancer Research and Treatment

Gene therapy strategies for carcinoma of the breast
pp. 93-114(22)
Authors: Ruppert J.M.; Wright M.; Rosenfeld M.; Grushcow J.; Bilbao G.; Curiel D.T.; Strong T.V.

Increased hematopoietic progenitor cell maintenance in long-term bone marrow cultures containing minimal numbers of contaminating breast cancer cells
pp. 115-121(7)
Authors: Mann S.L.; Joshi S.S.; Crouse D.A.; Armitage J.O.; Kessinger A.; Weisenburger D.D.; Vaughan W.P.; Sharp J.G.

The expression of Ki-S1 and BCL-2 and the response to primary tamoxifen therapy in elderly patients with breast cancer
pp. 123-133(11)
Authors: Keen J.C.; Dixon J.M.; Miller E.P.; Cameron D.A.; Chetty U.; Hanby A.; Bellamy C.; Miller W.R.

Weight gain associated with adjuvant tamoxifen therapy in stage I and II breast cancer: fact or artifact?
pp. 135-143(9)
Authors: Kumar N.B.; Allen K.; Cantor A.; Cox C.E.; Greenberg H.; Shah S.; Lyman G.H.

A point mutation in the human estrogen receptor gene is associated with the expression of an abnormal estrogen receptor mRNA containing a 69 novel nucleotide insertion
pp. 145-151(7)
Authors: Wang M.; Dotzlaw H.; Fuqua S.A.W.; Murphy L.C.

Isolation and analysis of different subpopulations of normal human breast epithelial cells early after their infection with a retroviral vector encoding a cell surface marker
pp. 153-165(13)
Authors: Bardy P.; Conneally E.; Emerman J.T.; Lansdorp P.M.; Goss G.; Humphries R.K.; Eaves C.J.

Prognostic factors for metachronous contralateral breast cancer: A comparison of the linear Cox regression model and its artificial neural network extension
pp. 167-178(12)
Authors: Mariani L.; Coradini D.; Biganzoli E.; Boracchi P.; Marubini E.; Pilotti S.; Salvadori B.; Silvestrini R.; Veronesi U.; Zucali R.; Rilke F.

MRI in patients with axillary metastases of occult breast carcinoma
pp. 178-182(4)
Authors: Tilanus-Linthorst M.M.A.; Obdeijn A.I.M.; Bontenbal M.; Oudkerk a.M.